Alexander Hoffman – Sanaria

Sanaria Reports Positive Initial Safety Results for Groundbreaking PfSPZ-LARC2 Malaria Vaccine

June 3, 2025 By Alexander Hoffman In News, Press Releases No Comments

Physician-scientists at Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have successfully completed initial safety evaluations in 30 adult Burkinabés as the first phase of a clinical trial of Sanaria® PfSPZ-LARC2 Vaccine, which is designed to prevent infection with Plasmodium falciparum malaria.

A Single-Dose Breakthrough: PfSPZ-LARC Vaccines Offer Transformative Protection Against Malaria

February 12, 2025 By Alexander Hoffman In News, Press Releases No Comments

Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, designed to provide high-level protection with just one dose. This innovative approach leverages decades of research and cutting-edge genetic engineering to combat one of the world’s deadliest diseases.

Sanaria’s CEO, Dr. Stephen L. Hoffman awarded the Walter Reed Medal at the American Society of Tropical Medicine’s Annual Conference

Sanaria’s CEO, Dr. Stephen L. Hoffman awarded the Walter Reed Medal at the American Society of Tropical Medicine’s Annual Conference

November 14, 2024 By Alexander Hoffman In Awards, In The Media No Comments

The Walter Reed Medal is awarded every year to recognize distinguished accomplishments in the field of tropical medicine.

International PfSPZ Consortium Met in New Orleans on November 11th & 12th, 2024

International PfSPZ Consortium Met in New Orleans on November 11th & 12th, 2024

November 12, 2024 By Alexander Hoffman In News No Comments

On November 11th and 12th, 2024, the International PfSPZ Consortium (i-PfSPZ-C) meeting was held as a hybrid event with members joining both virtually and in-person at the Tulane University, Celia Scott Weatherhead School of Public Health and Tropical Medicine located in downtown New Orleans, Louisiana.

Employee of the Month: Tint Wai

Employee of the Month: Tint Wai

September 5, 2024 By Alexander Hoffman In Employee of the Month, Uncategorized No Comments

The Sanaria employee of the month for August 2024 is Tint T. Wai. Tint was nominated for her work quality and work ethic.

Sanaria’s Recent Lancet ID Publication Featured in devex Article

August 30, 2024 By Alexander Hoffman In In The Media No Comments

Sanaria's recent publication in the Lancet Infectious Diseases was featured in an devex article entitled "The long road to a malaria vaccine that’s safe during pregnancy." This piece highlights the outstanding efficacy and safety over two years in Malian women of childbearing potential including protection during pregnancy - without a booster dose!

First-of-its-kind vaccine expands malaria protection for pregnant women

August 14, 2024 By Alexander Hoffman In In The Media, News, Press Releases, Publications No Comments

On August 14th, 2024, The Lancet Infectious Diseases released a publication entitled: "Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials."

Employee of the Month: Grace Jennings

August 13, 2024 By Alexander Hoffman In Employee of the Month No Comments

The Sanaria employee of the month for July 2024 is Grace Jennings. Grace is a member of the Mosquito Production team and was nominated for employee of the month for her team contributions and work ethic.

Indonesian collaborators and stake holders attend meeting in Jakarta to report successful results of trial of PfSPZ vaccines in Indonesian soldiers.

July 24, 2024 By Alexander Hoffman In In The Media, News No Comments

Overview: In 2022-2023, Sanaria® PfSPZ Vaccine and Sanaria® PfSPZ-CVac (CQ) malaria vaccines were assessed in a phase 2 clinical trial in Papua, Indonesia, against genetically diverse, naturally transmitted Plasmodium falciparum in malaria naïve, Indonesian military personnel. On July 17, 2024, the Faculty of Medicine, University of Indonesia (FMUI) hosted a scientific meeting in Jakarta, Indonesia attended by representatives of all the stakeholders to review the trial.

Sanaria Hosts Students from the National Student Leadership Conference

July 1, 2024 By Alexander Hoffman In News No Comments

On June 20th and 27th, Sanaria hosted over 100 students from the National Student Leadership Conference to teach them about Sanaria and it's mission to eradicate malaria.

Employee of the Month: James Overby

June 25, 2024 By Alexander Hoffman In Employee of the Month No Comments

Sanaria's Employee of the Month for June 2024 is James Overby

Sanaria® PfSPZ-LARC2 Vaccine the focus of a meeting at Germany’s biologics regulatory agency, the Paul-Ehrlich-Instit.

June 11, 2024 By Alexander Hoffman In In The Media, News No Comments

DZIF Workshop on Malaria Vaccine Development focuses on Sanaria® PfSPZ-LARC2 Vaccine

Employee of the Month: Swagatika Swain

June 4, 2024 By Alexander Hoffman In Employee of the Month No Comments

The Sanaria employee of the month for April 2024 is Swagatika Swain. Swagatika is a member of the Quality Assurance team and was nominated for employee of the month for recent efforts in managing her team’s workload.

Employees of the Month: Amparo Tellez and Marcus Prince

April 16, 2024 By Alexander Hoffman In Employee of the Month No Comments

The Sanaria employees of the month for March 2024 are Amparo Tellez and Marcus Prince. Amparo and Marus are members of the Manufacturing team and were nominated for employees of the month for their professionalism, consistency, and flexibility – which is key to prepare and maintain a clean and aseptic manufacturing environment that allows Sanaria operations to meet all regulatory standards.

Sanaria Wins Best Logistics Technology and Cold Chain Delivery Award

April 3, 2024 By Alexander Hoffman In Awards, News No Comments

On April 2nd, 2024, Sanaria Inc. won the Best Logistics Technology and Cold Chain Delivery Award at the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress in Washington, D.C.

Novel vaccine, PfSPZ-LARC2 Vaccine, to prevent malaria infection developed by Seattle Children’s Research Institute and Sanaria ready for human testing

April 1, 2024 By Alexander Hoffman In In The Media, News, Press Releases No Comments

In a report published on March 21, 2024 in EMBO Molecular Medicine (A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion) investigators at Seattle Children’s Research Institute and Sanaria Inc. describe the development of a whole malaria parasite vaccine strain that infects the liver, develops to the late liver stage, and then gets completely stuck and cannot burst out of the liver to cause symptomatic blood infection.

Sanaria®/Seattle Children’s PfSPZ-LARC2 Vaccine: finalist in Vaccine Industry Excellence (VIE) awards for Best Prophylactic Vaccine Award

March 7, 2024 By Alexander Hoffman In Awards, In The Media, Uncategorized No Comments

Sanaria®/Seattle Children's PfSPZ-LARC2 Vaccine: finalist in Vaccine Industry Excellence (VIE) awards for Best Prophylactic Vaccine Award!

Sanaria is a finalist in Vaccine Industry Excellence (VIE) awards for Best Logistics Technology & Cold Chain Delivery Award

March 6, 2024 By Alexander Hoffman In Awards, In The Media, Uncategorized No Comments

Sanaria is a finalist in Vaccine Industry Excellence (VIE) awards for Best Logistics Technology & Cold Chain Delivery Award!

Employee of the Month: Mei-Chun Chen

February 29, 2024 By Alexander Hoffman In Employee of the Month No Comments

The Sanaria employee of the month for February 2024 is Mei-Chun Chen. Mei is a member of the clinical team at Sanaria and was nominated for employee of the month in recognition of her superb work supporting the Indonesian soldier trial of PfSPZ Vaccine and PfSPZ-CVac.

Employee of the Month: Nafijah Khan

February 6, 2024 By Alexander Hoffman In Employee of the Month No Comments

The Sanaria employee of the month for January 2024 is Nafijah Khan. Nafijah carries herself with an air of professionalism which carries over into her work. She leads her team tackling all tasks, no matter how large or small, with the attention they deserve.

Contact Us

We welcome your feedback and inquiries. Please be in touch.

Address:

Sanaria Inc.
9610 Medical Center Drive, Suite 200
Rockville, MD 20850

Phone:

+1.301.770.3222

Email:

sanaria@sanaria.com

Social: